Suppr超能文献

喷射式雾化器和超声雾化器产生的肝素气雾剂的特性研究。

Characterization of heparin aerosols generated in jet and ultrasonic nebulizers.

作者信息

Bendstrup K E, Newhouse M T, Pedersen O F, Jensen J I

机构信息

Department of Internal Medicine, Esbjerg Hospital, Denmark.

出版信息

J Aerosol Med. 1999 Spring;12(1):17-25. doi: 10.1089/jam.1999.12.17.

Abstract

Inhaled heparin has been used for asthma treatment, but results have been inconsistent, probably due to highly varying lung doses. We determined the output per unit time and the particle size distributions of sodium heparin, calcium heparin, and low molecular weight (LMW) heparin formulations in five concentrations from Sidestream jet nebulizers (Medic-Aid, Bognor Regis, England) and an Ultraneb 2000 ultrasonic nebulizer (DeVilbiss, Langen, Germany). We also determined the inhaled mass and the estimated respirable mass for some combinations. For the jet nebulizer, output per minute increased with increasing concentration and flow rate, and particle size decreased from 3.64 to 2.01 microns (mass median diameter [MMD]). The percentage of particles less than 3 microns ranged from 41% to 74%. For the ultrasonic nebulizer, maximum output per minute was achieved at a concentration of 7000 i.u./mL; this maximum depended upon the viscosity and temperature of the solution. MMD was independent of formulation, temperature, or concentration and ranged from 5.61 to 7.03 microns. Sodium heparin/calcium heparin in a concentration of 20,000 i.u./mL in the jet nebulizer driven at 10 L/min produced the highest dose of heparin capable of reaching the lower respiratory tract. Mass balance was determined for these combinations with the jet nebulizer run until visible aerosol generation ceased. Of a loading dose of 80,000 i.u. of heparin, 45,000 i.u. remained in the dead space of the nebulizer, 20,000 i.u. was deposited on the exhalation filter, and 15,000 i.u. was captured on the inhalation filter (inhaled mass). This corresponds to a respirable mass of 10,000 i.u. of heparin with a high probability of reaching the lower respiratory tract in normal healthy adults.

摘要

吸入性肝素已用于哮喘治疗,但结果并不一致,这可能是由于肺部剂量差异很大。我们测定了来自侧流式喷射雾化器(Medic-Aid,博格诺里吉斯,英国)和Ultraneb 2000超声雾化器(德维比斯,朗根,德国)的五种浓度的肝素钠、肝素钙和低分子量(LMW)肝素制剂的单位时间输出量和粒径分布。我们还测定了某些组合的吸入质量和估计的可吸入质量。对于喷射雾化器,每分钟输出量随浓度和流速的增加而增加,粒径从3.64微米降至2.01微米(质量中值直径[MMD])。小于3微米的颗粒百分比范围为41%至74%。对于超声雾化器,在浓度为7000国际单位/毫升时达到每分钟最大输出量;这个最大值取决于溶液的粘度和温度。MMD与制剂、温度或浓度无关,范围为5.61至7.03微米。在以10升/分钟驱动的喷射雾化器中,浓度为20000国际单位/毫升的肝素钠/肝素钙产生了能够到达下呼吸道的最高剂量肝素。在喷射雾化器运行直至可见气溶胶产生停止的情况下,测定了这些组合的质量平衡。在80000国际单位的肝素负荷剂量中,45000国际单位留在雾化器的死腔内,20000国际单位沉积在呼气过滤器上,15000国际单位被吸入过滤器捕获(吸入质量)。这相当于10000国际单位的肝素可吸入质量,在正常健康成年人中极有可能到达下呼吸道。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验